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Swaroop Varghese, MBBS, Bernward Lauer, MD, Marc-Alexander Ohlow, MDA mong the rare complications after percuta-neous coronary intervention, coronary arteryaneurysms (CAA) reportedly have an inci-
dence of 0.3% to 6.0%. The detection of CAAs vary
from 3 days to up to 4 years after drug-eluting stent
(DES) and from 6 days to up to 6 years after bare-
metal stents (BMS) implantation. Associated factors
include residual dissection and deep arterial wall
injury caused by oversized balloons or stents, high-
pressure balloon inﬂations, atherectomy, and laser
angioplasty (1,2). Though the pathogenesis of CAA
after DES, as well as after BMS, implantation has
been studied, there seems to be neither sufﬁcient
literature nor adequate evidence of CAA after aFIGURE 1 Coronary Angiography of the Obtuse Marginal Branch
(A) Stenosis of the obtuse marginal branch (white arrow); (B) result imm
white arrow is the repaired stenosis of the obtuse marginal branch afte
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patient with exertional angina underwent percuta-
neous coronary intervention of the ﬁrst obtuse
marginal branch. After pre-dilation with a regular
balloon, a 3.0  18-mm bioabsorbable vascular scaf-
fold (BVS) (Absorb, Abbott Vascular, Santa Clara,
California) was positioned with good immediate
results (Figure 1). An angiographic and intravascular
ultrasound (IVUS) follow-up at 6 months revealed an
aneurysm in the stented segment (Figure 2). Due to
atypical complaints of the patient, an angiographic
and IVUS follow-up was recommended. At 1 year,
the aneurysm had signiﬁcantly increased in size
(Figure 3), and a covered stent (3.0  18 BeGraft,ediately after implantation of a bioabsorbable vascular scaffold. The
r implantation of a bioabsorbable stent.
many. The authors have reported that they have no
FIGURE 3 Coronary Angiography and IVUS After 12 Months
(A) Coronary angiography after 12 months: large aneurysmatic structure in the stented segment of the obtuse marginal branch (white arrow);
(B) intravascular ultrasound (IVUS): visualization of the aneurysmatic structure (asterisk).
FIGURE 2 Coronary Angiography and IVUS After 6 Months
(A) Coronary angiography after 6 months: aneurysmatic structure in the stented segment of the obtuse marginal branch (white arrow);
(B) intravascular ultrasound (IVUS): visualization of the aneurysmatic structure (black arrows).
FIGURE 4 Coronary Angiography: Final Result
Coronary angiography: ﬁnal result of the obtuse marginal branch after im-
plantation of a covered stent in the aneurysmatic region (white arrow).
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e24Bentley InnoMed, Hechingen) was implanted to ex-
clude the aneurysm (Figure 4). It could be hypothe-
sized that the distinct morphological attributes of
the BVS stent such as relatively thicker struts and
the slower expandability requiring higher pressures
of balloon inﬂations (thereby causing deep arterial
wall injury) during implantation as well as inﬂamma-
tory/hypersensitivity changes (occurring in the vessel
wall) after implantation could play a multifactorial
role in the pathogenesis of a CAA (2). Further studies
are desired to comprehensively study the incidence
and understand the underlying pathomechanisms of
CAAs after bioabsorbable stent implantation.
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